Go Pro
→ Musk says UBI is coming. I say it's already here. (From Freedom Financial) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biofrontera Inc. stock logo
BFRIW
Biofrontera
$0.02
+3.0%		$0.03
$0.02
▼
$0.15
N/AN/A6,095 shs1,663 shs
CINGW
Cingulate
$0.01
-33.5%		$0.01
$0.00
▼
$0.12
N/AN/A33,436 shs2,473 shs
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$0.03
$0.03
$0.02
▼
$0.15
N/AN/A9,959 shs2 shs
VCKAW
Vickers Vantage Corp. I
$0.12
-4.0%		$0.17
$0.10
▼
$0.73
N/AN/A16,030 shs4,388 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biofrontera Inc. stock logo
BFRIW
Biofrontera
0.00%-20.00%-33.11%-11.50%-80.00%
CINGW
Cingulate
0.00%+20.00%+22.58%-51.07%-83.71%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00%-6.27%+34.90%-11.80%-50.72%
VCKAW
Vickers Vantage Corp. I
0.00%-26.66%-44.83%-17.05%-73.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biofrontera Inc. stock logo
BFRIW
Biofrontera
$0.02
+3.0%		$0.03
$0.02
▼
$0.15
N/AN/A6,095 shs1,663 shs
CINGW
Cingulate
$0.01
-33.5%		$0.01
$0.00
▼
$0.12
N/AN/A33,436 shs2,473 shs
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$0.03
$0.03
$0.02
▼
$0.15
N/AN/A9,959 shs2 shs
VCKAW
Vickers Vantage Corp. I
$0.12
-4.0%		$0.17
$0.10
▼
$0.73
N/AN/A16,030 shs4,388 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biofrontera Inc. stock logo
BFRIW
Biofrontera
0.00%-20.00%-33.11%-11.50%-80.00%
CINGW
Cingulate
0.00%+20.00%+22.58%-51.07%-83.71%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00%-6.27%+34.90%-11.80%-50.72%
VCKAW
Vickers Vantage Corp. I
0.00%-26.66%-44.83%-17.05%-73.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biofrontera Inc. stock logo
BFRIW
Biofrontera
0.00
N/AN/AN/A
CINGW
Cingulate
0.00
N/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00
N/AN/AN/A
VCKAW
Vickers Vantage Corp. I
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biofrontera Inc. stock logo
BFRIW
Biofrontera
$46.18MN/AN/AN/AN/AN/A
CINGW
Cingulate
N/AN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$1.11MN/AN/AN/AN/AN/A
VCKAW
Vickers Vantage Corp. I
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biofrontera Inc. stock logo
BFRIW
Biofrontera
N/AN/AN/AN/AN/AN/AN/AN/A11/18/2026 (Estimated)
CINGW
Cingulate
N/AN/AN/AN/AN/AN/AN/AN/A11/18/2026 (Estimated)
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
VCKAW
Vickers Vantage Corp. I
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biofrontera Inc. stock logo
BFRIW
Biofrontera
N/AN/AN/AN/AN/A
CINGW
Cingulate
N/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/A
VCKAW
Vickers Vantage Corp. I
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Biofrontera Inc. stock logo
BFRIW
Biofrontera
N/A
CINGW
Cingulate
N/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/A
VCKAW
Vickers Vantage Corp. I
N/A

Insider Ownership

CompanyInsider Ownership
Biofrontera Inc. stock logo
BFRIW
Biofrontera
N/A
CINGW
Cingulate
N/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/A
VCKAW
Vickers Vantage Corp. I
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Biofrontera Inc. stock logo
BFRIW
Biofrontera
70N/AN/ANot Optionable
CINGW
Cingulate
20N/AN/ANot Optionable
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
2N/AN/ANot Optionable
VCKAW
Vickers Vantage Corp. I
N/AN/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Biofrontera stock logo

Biofrontera NASDAQ:BFRIW

$0.02 +0.00 (+3.00%)
As of 02:24 PM Eastern

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Cingulate NASDAQ:CINGW

$0.0075 0.00 (-33.54%)
As of 03:43 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

60 Degrees Pharmaceuticals stock logo

60 Degrees Pharmaceuticals NASDAQ:SXTPW

$0.03 0.00 (0.00%)
As of 09/4/2026

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

Vickers Vantage Corp. I NASDAQ:VCKAW

$0.12 0.00 (-3.98%)
As of 09/4/2026

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas